Searched for
ALLERGAN INC
Piramal Pharma lists share on BSE, NSEIn October 2021, the board of directors of PEL approved the demerger of the pharmaceuticals business and simplification of the corporate st...- Strides Pharma gets USFDA nod for generic drugBengaluru-based Strides Pharma has 127 cumulative abbreviated new drug applications (ANDA) filings with USFDA of which 96 have been approve...
- Granules India gets USFDA nod for overactive bladder treatment capsule"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wh...
- Alembic gets USFDA nod for generic ophthalmic solutionAlembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market Alcaftadine ophthalmic solution, in ...
- Big pharma returning to US price hikes in January after pausePfizer has already announced plans to hike prices on 41 of its drugs in mid-January.
- Glenmark Pharmaceuticals gets USFDA nod for contraceptive drugsThe company's current portfolio consists of 137 products authorised for distribution at the US marketplace and 61 Abbreviated New Drug Appl...
- Allergan to buy Acelity's tissue unit LifeCell for $2.9 billionAllergan Chief Executive Brent Saunders has described the company's acquisition strategy as being one of "stepping stones." Allergan's deal...
- Pfizer to buy Allergan in $160 billion deal to create world's No 1 drugmakerNew York-based Pfizer and Allergan, headquartered in Ireland, said on Monday that Pfizer would offer 11.3 of its own shares for each Allerg...
- Brent Saunders gets key job as Pfizer, Allergan combineSaunders, 45, an intrepid deal maker, has a history of eventually leading companies that he had helped combine.
- Cipla, Glenmark in race for hived-off Teva-Allergan generics in USSources indicated that Indian drug makers will be keen to buy the generic portfolio on offer, which could be valued at a minimum of $500 mi...
- Lupin pharma gets USFDA nod to market ophthalmic solutionThe company said it has received the final approval for its product, a generic version of Allergan Inc's Lumigan Ophthalmic Solution, from ...
- Allergan Inc eyes Rs 1,000 crore in revenues from India by 2017-18"Our dream is to touch Rs 1,000 crore revenue figure by 2017-18. We are on track to get it on the back of what we have created here."
- Lupin launches generic ophthalmic solution in US marketLupin launched generic version of Allergan Inc's Zymaxid Ophthalmic Solution in US market with 180 days of marketing exclusivity.
- IPAB revokes two Allergan patents on Ajanta Pharma challengeDrug firm Ajanta Pharma today said it has been successful in its challenge to revoke patents held by Allergan Inc for two drugs used for ey...
- Wellness market may touch $20 billion in next 3-4 yrsCurrently the size of the wellness market in India stood at about $ 10 billion, Allergan India Managing Director Raghu Kumar said.
- Allergan launches 'Juvederm XC' in IndiaUS-based Allergan Inc today announced the launch of its anaesthetic dermal filler 'Juvederm XC', used to correct facial imperfections, in t...
- Allergan to introduce more products for enhancing businessUS-based pharmaceutical firm Allergan today said that it is looking at expanding its product range in India as part of a strategy to enhanc...
- US jobless claims hit 26-year high of 626,000As a proportion of the work force, the number of people receiving unemployment benefits is at the highest level since August 1982. Coming t...
- Allegran arm to sell Botox productsAmerican drug company Allergan Pharmaceuticals is setting up a wholly-owned subsidiary to sell Botox products, used as muscle relaxants and...
- Allergan opens pharma R&D company in IndiaUS-based Allergan Inc today launched a pharmaceutical research and development (R&D) firm here.
Load More
